News | November 06, 2024
Granules India Q2 FY25 PAT drops 5% YoY to Rs. 97 Cr
Revenue share from the North America increased to 79% in Q2 FY25 as compared to 67% in Q2 FY24
Revenue share from the North America increased to 79% in Q2 FY25 as compared to 67% in Q2 FY24
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
DKSH has entered into an exclusive partnership with R-Biomeds to bring the necessary medication to patients in Cambodia
The OPTASE range is a safe, tested and expert recommended 3-step regime to help tackle the cause and symptoms of eye conditions
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
Pfizer's decision is based on the totality of clinical data
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
Subscribe To Our Newsletter & Stay Updated
